Summary
- Current Price
- As of today, ELVN price is $49.43, up +10.36% on
- Current Price All-Time High
- ELVN price is currently -21.18% below its historical high of $62.71 set on
- Market Cap
- ELVN current market cap is $4B, up +233.96% over the past 365 days
- Revenue
- ELVN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ELVN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Enliven Therapeutics, Inc. |
| Ticker | NASDAQ: ELVN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | enliventherapeutics.com |
| Employees | 65 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $49.43 | |
| Price, 1D Change | +10.36% | |
| $4B | ||
| - | ||
| - | ||
| 1.12 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.83 | ||
| EPS, 1Y Change | +3.24% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | IMRA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.83 | ||
| EPS Estimate | -$1.91 | N/A |
| EPS Est. Change | -4.59% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $49.43 | |
| Price Target | $74.00 | - |
| Price Tgt. Change | +49.71% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.59 | -$1.89 | -18.94% | |
| -$1.80 | -$1.83 | -1.67% | |
| -$1.91 | N/A | -4.59% | |
| -$2.32 | N/A | -26.63% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $10.00K | $0.00 | -100.00% | |
| - | N/A | - | |
| $5,000.00 | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $49.43 | |
| $43.22 | ||
| $47.25 | ||
| $42.84 | ||
| $46.34 | ||
| $0.27 | ||
| 1.12 | ||
| $2.22 | ||
| 63.71 | ||
| 68.75% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.83 | ||
| -$263.00K | ||
| - | ||
| -$119.66M | ||
| - | ||
| -$103.69M | ||
| - | ||
| -$119.40M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 28.66 | ||
| 28.66 | ||
| - | ||
| - | ||
| 129.62 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.05 | ||
| -21.95 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $459.60M | ||
| $462.62M | ||
| $476.28M | ||
| $474.88M | ||
| $16.68M | ||
| $16.57M | ||
| $399.00K | ||
| $399.00K | ||
| $2.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $103.69M | ||
| $119.40M | ||
| $263.00K | ||
| $0.00 | ||
| $263.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$70.30M | ||
| -$173.84M | ||
| $218.87M | ||
| $158.00K | ||
| -$70.46M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Morgan Stanley | ||
| JP Morgan | ||
| William Blair | ||
| Mizuho | → | |
| Barclays | ||
| Stifel | → | |
| Guggenheim | → | |
| Goldman Sachs | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with ELVN
FAQ
- What is the ticker symbol for Enliven Therapeutics, Inc.?
- The ticker symbol for Enliven Therapeutics, Inc. is NASDAQ:ELVN
- Does Enliven Therapeutics, Inc. pay dividends?
- No, Enliven Therapeutics, Inc. does not pay dividends
- What sector is Enliven Therapeutics, Inc. in?
- Enliven Therapeutics, Inc. is in the Healthcare sector
- What industry is Enliven Therapeutics, Inc. in?
- Enliven Therapeutics, Inc. is in the Biotechnology industry
- What country is Enliven Therapeutics, Inc. based in?
- Enliven Therapeutics, Inc. is headquartered in United States
- When did Enliven Therapeutics, Inc. go public?
- Enliven Therapeutics, Inc. initial public offering (IPO) was on March 12, 2020
- Is Enliven Therapeutics, Inc. in the S&P 500?
- No, Enliven Therapeutics, Inc. is not included in the S&P 500 index
- Is Enliven Therapeutics, Inc. in the NASDAQ 100?
- No, Enliven Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Enliven Therapeutics, Inc. in the Dow Jones?
- No, Enliven Therapeutics, Inc. is not included in the Dow Jones index
- When was Enliven Therapeutics, Inc. last earnings report?
- Enliven Therapeutics, Inc.'s most recent earnings report was on November 5, 2026
- When does Enliven Therapeutics, Inc. report earnings?
- The date for Enliven Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ELVN Official Website www.enliventherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1672619/000119312526088232/0001193125-26-088232-index.htm
- ELVN Profile on Yahoo Finance finance.yahoo.com/quote/ELVN
- ELVN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elvn